首页> 中文期刊> 《中国临床保健杂志》 >N-末端脑钠肽原用于急性心力衰竭诊断的价值评估

N-末端脑钠肽原用于急性心力衰竭诊断的价值评估

         

摘要

目的:探讨 N-末端脑钠肽原对急性心力衰竭诊断的价值。方法选择就诊的急性心力衰竭的患者106例,另选对照组52例,来源于同期因胸闷、气喘、呼吸困难就诊的患者,临床诊断排除急性心力衰竭,分别测定血浆 N-末端脑钠肽原浓度,比较不同组患者的血浆 N-末端脑钠肽原水平。结果≥75岁人群中,急性心力衰竭组 N-末端脑钠肽原(88.41±14.72)pmol/L 与对照组 N-末端脑钠肽原(33.27±6.61)pmol/L 比较,t =18.57,P <0.05。<75岁人群中,急性心力衰竭组 N-末端脑钠肽原(32.73±5.97)pmol/L 与对照组 N-末端脑钠肽原(6.12±2.51)pmol/L 比较,t =27.28,P <0.05。结论急性心力衰竭患者 N-末端脑钠肽原明显升高,N-末端脑钠肽原对急性心力衰竭诊断有意义。%Objective To explore the value of N-terminal brain natriuretic peptide in the diagnosis of acute heart failure.Methods A total of 158 patients with dyspnea were selected,including 106 patients with acute heart fail-ure and 52 controls and 52 controls with other diease.The N-terminal brain natriuretic peptide were measured and com-pared.Results The N-terminal brain natriuretic peptide of acute heart failure[(88.41 ±14.72)pmol/L ]was signifi-cantly higher than that of the control group[(33.27 ±6.61)pmol/L]in people aged 75 years or older (t =18.57,P <0.05).The N-terminal brain natriuretic peptide of acute heart failure[(32.73 ±5.97)pmol/L]was significantly higher than that of the control group[(6.12 ±2.51)pmol/L](t =27.28,P <0.05).Conclusion The N-terminal brain natri-uretic peptide is significantly increased in patients with acute heart failure,N-terminal brain natriuretic peptide detection has some diagnose value in patients with acute heart failure.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号